VTYX
Ventyx Biosciences, Inc.$14.00+0.00 (—)Prev Close—·MCap$1.00B·P/E—·Vol—·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
2
$463.3K
◆
Net Activity
Net Seller
$463.3K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Ventyx Biosciences, Inc. (VTYX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 2 insider sales totaling $463.3K. The most recent insider transaction was by Mohan Raju (CEO AND PRESIDENT), who sold $365.5K worth of shares on Dec 17, 2025. Ventyx Biosciences, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.00B.
VTYX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Mohan Raju | CEO AND PRESIDENT | Sell | 47,345 | $7.72 | $365.5K | 0 |
| Dec 17, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 12,675 | $7.72 | $97.8K | 0 |
| Dec 30, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 21,119 | $2.36 | $49.8K | 464,582 |
| Dec 26, 2024 | Gujrathi Sheila | Buy | 130,000 | $2.31 | $300.6K | 130,000 | |
| Dec 19, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 13,161 | $2.26 | $29.7K | 485,701 |
| Nov 25, 2024 | Mohan Raju | CEO AND PRESIDENT | Buy | 500,000 | $1.92 | $959.9K | 2,175,028 |
| Apr 3, 2024 | Auster Martin | CHIEF FINANCIAL OFFICER | Sell | 1,405 | $5.40 | $7.6K | 24,303 |
| Apr 3, 2024 | Krueger Christopher W | CHIEF BUSINESS OFFICER | Sell | 1,651 | $5.40 | $8.9K | 284,999 |
| Apr 3, 2024 | Mohan Raju | CEO AND PRESIDENT | Sell | 4,312 | $5.40 | $23.3K | 1,578,250 |
| Apr 3, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 1,651 | $5.40 | $8.9K | 264,998 |
| Dec 21, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 5,293 | $2.12 | $11.2K | 282,119 |
| Dec 21, 2023 | Mohan Raju | CEO and President | Sell | 58,860 | $2.12 | $124.7K | 1,570,719 |
| Dec 21, 2023 | Nuss John | Chief Scientific Officer | Sell | 17,628 | $2.12 | $37.3K | 262,118 |
| Oct 11, 2023 | NSV Partners III LP | 10% Owner | Sell | 49,152 | $30.03 | $1.48M | 8,439,635 |
| Oct 6, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $29.11 | $873.2K | 1,512,911 |
| Oct 4, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $29.98 | $449.7K | 277,542 |
| Oct 4, 2023 | Nuss John | Chief Scientific Officer | Sell | 10,000 | $29.99 | $299.9K | 245,538 |
| Sep 20, 2023 | Subramaniam Somu | Director | Sell | 56,665 | $37.81 | $2.14M | 8,488,787 |
| Sep 7, 2023 | Auster Martin | Chief Financial Officer | Sell | 26,472 | $32.61 | $863.3K | 29,322 |
| Sep 7, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $32.61 | $489.1K | 281,117 |
| Sep 7, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $32.61 | $978.3K | 1,522,281 |
| Sep 7, 2023 | Nuss John | Chief Scientific Officer | Sell | 10,000 | $32.60 | $326.0K | 247,824 |
| Sep 1, 2023 | Sandborn William J. | See Remarks | Sell | 11,900 | $33.64 | $400.4K | 48,389 |
| Aug 8, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $33.52 | $1.01M | 1,522,686 |
| Aug 8, 2023 | Sandborn William J. | See Remarks | Sell | 3,494 | $32.86 | $114.8K | 25,602 |
| Aug 4, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $35.59 | $533.8K | 278,248 |
| Aug 4, 2023 | Nuss John | Chief Scientific Officer | Sell | 10,000 | $35.60 | $356.0K | 245,928 |
| Aug 1, 2023 | Sandborn William J. | See Remarks | Sell | 11,900 | $37.16 | $442.3K | 48,389 |
| Aug 1, 2023 | Subramaniam Somu | Director | Sell | 11,414 | $37.58 | $429.0K | 8,556,255 |
| Jul 26, 2023 | Auster Martin | Chief Financial Officer | Sell | 28,000 | $35.54 | $995.0K | 47,649 |
| Jul 13, 2023 | NSV Partners III LP | Sell | 31,921 | $37.55 | $1.20M | 8,560,141 | |
| Jul 11, 2023 | Subramaniam Somu | Sell | 100,000 | $35.23 | $3.52M | 9,577,279 | |
| Jul 6, 2023 | NSV Partners III LP | 10% Owner | Sell | 134,080 | $39.00 | $5.23M | 9,782,002 |
| Jul 5, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $39.22 | $588.3K | 291,145 |
| Jul 5, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $38.37 | $1.15M | 1,525,613 |
| Jul 5, 2023 | Nuss John | Chief Scientific Officer | Sell | 20,000 | $39.58 | $791.6K | 264,488 |
| Jul 5, 2023 | Sandborn William J. | See Remarks | Sell | 15,387 | $40.00 | $615.5K | 48,389 |
| Jun 27, 2023 | Sandborn William J. | See Remarks | Sell | 10,790 | $32.70 | $352.8K | 57,064 |
| Jun 16, 2023 | Sandborn William J. | See Remarks | Sell | 3,487 | $34.15 | $119.1K | 32,279 |
| Jun 16, 2023 | Subramaniam Somu | Director | Sell | 50,000 | $35.08 | $1.75M | 9,787,045 |
| Jun 8, 2023 | Subramaniam Somu | Director | Sell | 40,000 | $35.59 | $1.42M | 9,872,917 |
| Jun 7, 2023 | Auster Martin | Chief Financial Officer | Sell | 28,000 | $34.64 | $970.0K | 51,403 |
| Jun 7, 2023 | Nuss John | Chief Scientific Officer | Sell | 10,000 | $34.35 | $343.5K | 246,493 |
| Jun 6, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $34.36 | $515.4K | 278,665 |
| Jun 6, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $34.36 | $1.03M | 1,516,160 |
| Jun 1, 2023 | Sandborn William J. | See Remarks | Sell | 10,629 | $34.26 | $364.2K | 48,389 |
| May 16, 2023 | Sandborn William J. | See Remarks | Sell | 3,487 | $36.47 | $127.2K | 36,171 |
| May 5, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $39.28 | $1.18M | 1,543,126 |
| May 4, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $38.65 | $579.7K | 285,363 |
| May 4, 2023 | Nuss John | Chief Scientific Officer | Sell | 10,000 | $38.64 | $386.4K | 250,710 |
Showing 1–50 of 77
1 / 2
VTYX Insider Buying Activity
The following table shows recent insider purchases of Ventyx Biosciences, Inc. (VTYX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | Gujrathi Sheila | Buy | 130,000 | $2.31 | $300.6K | 130,000 | |
| Nov 25, 2024 | Mohan Raju | CEO AND PRESIDENT | Buy | 500,000 | $1.92 | $959.9K | 2,175,028 |
VTYX Insider Selling Activity
The following table shows recent insider sales of Ventyx Biosciences, Inc. (VTYX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | Mohan Raju | CEO AND PRESIDENT | Sell | 47,345 | $7.72 | $365.5K | 0 |
| Dec 17, 2025 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 12,675 | $7.72 | $97.8K | 0 |
| Dec 30, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 21,119 | $2.36 | $49.8K | 464,582 |
| Dec 19, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 13,161 | $2.26 | $29.7K | 485,701 |
| Apr 3, 2024 | Auster Martin | CHIEF FINANCIAL OFFICER | Sell | 1,405 | $5.40 | $7.6K | 24,303 |
| Apr 3, 2024 | Krueger Christopher W | CHIEF BUSINESS OFFICER | Sell | 1,651 | $5.40 | $8.9K | 284,999 |
| Apr 3, 2024 | Mohan Raju | CEO AND PRESIDENT | Sell | 4,312 | $5.40 | $23.3K | 1,578,250 |
| Apr 3, 2024 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 1,651 | $5.40 | $8.9K | 264,998 |
| Dec 21, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 5,293 | $2.12 | $11.2K | 282,119 |
| Dec 21, 2023 | Mohan Raju | CEO and President | Sell | 58,860 | $2.12 | $124.7K | 1,570,719 |
| Dec 21, 2023 | Nuss John | Chief Scientific Officer | Sell | 17,628 | $2.12 | $37.3K | 262,118 |
| Oct 11, 2023 | NSV Partners III LP | 10% Owner | Sell | 49,152 | $30.03 | $1.48M | 8,439,635 |
| Oct 6, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $29.11 | $873.2K | 1,512,911 |
| Oct 4, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $29.98 | $449.7K | 277,542 |
| Oct 4, 2023 | Nuss John | Chief Scientific Officer | Sell | 10,000 | $29.99 | $299.9K | 245,538 |
| Sep 20, 2023 | Subramaniam Somu | Director | Sell | 56,665 | $37.81 | $2.14M | 8,488,787 |
| Sep 7, 2023 | Auster Martin | Chief Financial Officer | Sell | 26,472 | $32.61 | $863.3K | 29,322 |
| Sep 7, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $32.61 | $489.1K | 281,117 |
| Sep 7, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $32.61 | $978.3K | 1,522,281 |
| Sep 7, 2023 | Nuss John | Chief Scientific Officer | Sell | 10,000 | $32.60 | $326.0K | 247,824 |
| Sep 1, 2023 | Sandborn William J. | See Remarks | Sell | 11,900 | $33.64 | $400.4K | 48,389 |
| Aug 8, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $33.52 | $1.01M | 1,522,686 |
| Aug 8, 2023 | Sandborn William J. | See Remarks | Sell | 3,494 | $32.86 | $114.8K | 25,602 |
| Aug 4, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $35.59 | $533.8K | 278,248 |
| Aug 4, 2023 | Nuss John | Chief Scientific Officer | Sell | 10,000 | $35.60 | $356.0K | 245,928 |
| Aug 1, 2023 | Sandborn William J. | See Remarks | Sell | 11,900 | $37.16 | $442.3K | 48,389 |
| Aug 1, 2023 | Subramaniam Somu | Director | Sell | 11,414 | $37.58 | $429.0K | 8,556,255 |
| Jul 26, 2023 | Auster Martin | Chief Financial Officer | Sell | 28,000 | $35.54 | $995.0K | 47,649 |
| Jul 13, 2023 | NSV Partners III LP | Sell | 31,921 | $37.55 | $1.20M | 8,560,141 | |
| Jul 11, 2023 | Subramaniam Somu | Sell | 100,000 | $35.23 | $3.52M | 9,577,279 | |
| Jul 6, 2023 | NSV Partners III LP | 10% Owner | Sell | 134,080 | $39.00 | $5.23M | 9,782,002 |
| Jul 5, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $39.22 | $588.3K | 291,145 |
| Jul 5, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $38.37 | $1.15M | 1,525,613 |
| Jul 5, 2023 | Nuss John | Chief Scientific Officer | Sell | 20,000 | $39.58 | $791.6K | 264,488 |
| Jul 5, 2023 | Sandborn William J. | See Remarks | Sell | 15,387 | $40.00 | $615.5K | 48,389 |
| Jun 27, 2023 | Sandborn William J. | See Remarks | Sell | 10,790 | $32.70 | $352.8K | 57,064 |
| Jun 16, 2023 | Sandborn William J. | See Remarks | Sell | 3,487 | $34.15 | $119.1K | 32,279 |
| Jun 16, 2023 | Subramaniam Somu | Director | Sell | 50,000 | $35.08 | $1.75M | 9,787,045 |
| Jun 8, 2023 | Subramaniam Somu | Director | Sell | 40,000 | $35.59 | $1.42M | 9,872,917 |
| Jun 7, 2023 | Auster Martin | Chief Financial Officer | Sell | 28,000 | $34.64 | $970.0K | 51,403 |
| Jun 7, 2023 | Nuss John | Chief Scientific Officer | Sell | 10,000 | $34.35 | $343.5K | 246,493 |
| Jun 6, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $34.36 | $515.4K | 278,665 |
| Jun 6, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $34.36 | $1.03M | 1,516,160 |
| Jun 1, 2023 | Sandborn William J. | See Remarks | Sell | 10,629 | $34.26 | $364.2K | 48,389 |
| May 16, 2023 | Sandborn William J. | See Remarks | Sell | 3,487 | $36.47 | $127.2K | 36,171 |
| May 5, 2023 | Mohan Raju | Chief Executive Officer | Sell | 30,000 | $39.28 | $1.18M | 1,543,126 |
| May 4, 2023 | Krueger Christopher W | Chief Business Officer | Sell | 15,000 | $38.65 | $579.7K | 285,363 |
| May 4, 2023 | Nuss John | Chief Scientific Officer | Sell | 10,000 | $38.64 | $386.4K | 250,710 |
VTYX Insiders
Similar Stocks to VTYX
VRTX
Vertex Pharmaceuticals Incorporated
$454.00-0.96%
$115.32B
REGN
Regeneron Pharmaceuticals, Inc.
$732.87-0.89%
$76.15B
ALNY
Alnylam Pharmaceuticals, Inc.
$312.17+0.99%
$41.40B
INSM
Insmed Incorporated
$136.00-4.42%
$29.32B
UTHR
United Therapeutics Corporation
$524.28-0.61%
$23.50B
MRNA
Moderna, Inc.
$50.80-3.04%
$20.76B
ROIV
Roivant Sciences Ltd.
$27.22-2.16%
$20.08B
RPRX
Royalty Pharma plc
$45.37-0.35%
$19.56B